NO168173C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater

Info

Publication number
NO168173C
NO168173C NO862485A NO862485A NO168173C NO 168173 C NO168173 C NO 168173C NO 862485 A NO862485 A NO 862485A NO 862485 A NO862485 A NO 862485A NO 168173 C NO168173 C NO 168173C
Authority
NO
Norway
Prior art keywords
branched
straight
alkyl
imidazolidinacetamide
oxo
Prior art date
Application number
NO862485A
Other languages
English (en)
Norwegian (no)
Other versions
NO168173B (no
NO862485L (no
NO862485D0 (no
Inventor
Mario Pinza
Ugo Pfeiffer
Carlo Farina
Silvano Banfi
Original Assignee
Isf Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isf Spa filed Critical Isf Spa
Publication of NO862485D0 publication Critical patent/NO862485D0/no
Publication of NO862485L publication Critical patent/NO862485L/no
Publication of NO168173B publication Critical patent/NO168173B/no
Publication of NO168173C publication Critical patent/NO168173C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO862485A 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater NO168173C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8521235A IT1209644B (it) 1985-06-21 1985-06-21 Composti farmacologicamente attivi.

Publications (4)

Publication Number Publication Date
NO862485D0 NO862485D0 (no) 1986-06-20
NO862485L NO862485L (no) 1986-12-22
NO168173B NO168173B (no) 1991-10-14
NO168173C true NO168173C (no) 1992-01-22

Family

ID=11178813

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862485A NO168173C (no) 1985-06-21 1986-06-20 Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5-oxo-1-imidazolidinacetamid-derivater

Country Status (19)

Country Link
US (1) US4719222A (de)
EP (1) EP0206729B1 (de)
JP (1) JPH0696558B2 (de)
KR (1) KR870000304A (de)
AT (1) ATE60787T1 (de)
AU (1) AU586259B2 (de)
CA (1) CA1271598A (de)
DE (1) DE3677418D1 (de)
DK (1) DK290486A (de)
ES (1) ES8800165A1 (de)
FI (1) FI862421L (de)
GR (1) GR861579B (de)
HU (1) HUT41740A (de)
IL (1) IL79137A (de)
IT (1) IT1209644B (de)
NO (1) NO168173C (de)
PH (1) PH22131A (de)
PT (1) PT82814B (de)
ZA (1) ZA864447B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico
FR2677984B1 (fr) * 1991-06-21 1994-02-25 Elf Sanofi Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant.
CA2225325A1 (en) * 1997-12-19 1999-06-19 The University Of British Columbia Hemiasterlin analogs
WO2008132142A2 (en) * 2007-04-27 2008-11-06 Ucb Pharma S.A. New heterocyclic derivatives useful for the treatment of cns disorders
EP3096666B1 (de) 2014-01-22 2021-06-16 Helen of Troy Limited Mop mit austauschbarem sekundärem reinigungskopf
CA3200430A1 (en) * 2021-05-26 2022-12-01 Sean N. Natoli Pro-benefit-agent compounds with heterocyclic moieties
JP7695359B2 (ja) 2021-05-26 2025-06-18 ザ プロクター アンド ギャンブル カンパニー 炭素/窒素結合を有するプロ有益剤化合物
EP4450489A1 (de) * 2023-04-18 2024-10-23 Synaffix B.V. Stabile 4-isoxazolinkonjugate
WO2024218162A1 (en) * 2023-04-17 2024-10-24 Synaffix B.V. Cleavable immune cell engagers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449029A (de) * 1963-08-12 1967-12-31 Hoffmann La Roche Verfahren zur Herstellung von 4-Imidazolidon-Verbindungen
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
IT1222367B (it) * 1985-06-21 1990-09-05 Isf Spa Amminoacil derivati di 4(5)-imidazolodinoni adattivita' nootropica:loro preparazione ed uso farmaceutico

Also Published As

Publication number Publication date
KR870000304A (ko) 1987-02-17
ES556352A0 (es) 1987-11-01
DE3677418D1 (de) 1991-03-14
AU586259B2 (en) 1989-07-06
NO168173B (no) 1991-10-14
DK290486A (da) 1987-02-23
PT82814A (en) 1986-07-01
IT8521235A0 (it) 1985-06-21
US4719222A (en) 1988-01-12
FI862421A7 (fi) 1986-12-22
PH22131A (en) 1988-06-01
AU5891886A (en) 1986-12-24
HUT41740A (en) 1987-05-28
NO862485L (no) 1986-12-22
IT1209644B (it) 1989-08-30
FI862421L (fi) 1986-12-22
EP0206729A3 (en) 1989-01-11
PT82814B (pt) 1988-04-21
EP0206729A2 (de) 1986-12-30
FI862421A0 (fi) 1986-06-06
CA1271598A (en) 1990-07-10
NO862485D0 (no) 1986-06-20
DK290486D0 (da) 1986-06-20
ATE60787T1 (de) 1991-02-15
ZA864447B (en) 1987-02-25
IL79137A (en) 1991-07-18
GR861579B (en) 1986-10-21
JPH0696558B2 (ja) 1994-11-30
JPS6230762A (ja) 1987-02-09
EP0206729B1 (de) 1991-02-06
ES8800165A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
NO165799C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte 2-oksindol-1-karboksamider og mellomprodukter for anvendelse ved fremgansmaaten.
IT1209644B (it) Composti farmacologicamente attivi.
NO168428C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt pyrrolidonderivat
NO166409C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oksadiazol-forbindelser.
PT643061E (pt) Novos antibioticos de cefalosporina e processos para a sua preparacao